Sterile individual set for producing biopharmaceutical products

US9963255B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9963255-B2
Application numberUS-201314390838-A
CountryUS
Kind codeB2
Filing dateApr 19, 2013
Priority dateApr 24, 2012
Publication dateMay 8, 2018
Grant dateMay 8, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A sterile individual set for use in a process of manufacturing a biopharmaceutical product. To make it quicker and easier to grasp and use fluidic type functional members, the sterile individual set includes a sterile flexible bag having a peripheral wall defining a sterile internal space and a fluidic type functional member arranged at least partially inside the sterile internal space. The functional member includes one or more communication duct(s) arranged in the sterile internal space. The sterile individual set also includes structural association elements capable of holding together several portions of the communication duct or ducts that are to be bundled together into a bundle. The structural association elements have an external surface with lower static and dynamic friction coefficients so as to make the functional member easier to handle by slippage of the bundle of communication ducts with respect to the peripheral wall of the flexible bag.

First claim

Opening claim text (preview).

The invention claimed is: 1. A sterile individual set intended for use in the process of manufacturing a biopharmaceutical product, the set comprising: a sterile flexible bag provided with a peripheral wall defining a sterile internal space and a fluidic-type functional member arranged at least partially within said sterile internal space, the functional member comprising one or more communication conduit(s) arranged within the sterile internal space, adapted to ensure the sterile fluid transfer of fluid components and having an external surface; and structural association elements, arranged within the sterile internal space and adapted to hold a plurality of portions to be bundled of the communication conduits(s) close to one another so as to constitute a bundle of communication conduits forming a structural unit that can be manipulated as such, wherein the structural association elements are arranged about and along the bundle of communication conduits and have an external surface with static and dynamic friction coefficients that are lower than those of the external surface of the one or more communication conduit(s) of the functional member, so as to facilitate manipulation of the functional member by sliding said bundle of communication conduits relative to the peripheral wall of the flexible bag. 2. The sterile individual set according to claim 1 , wherein the structural association elements comprise at least one open or closed component section that is elastically deformable so as to clamp the portions to be bundled of the communication conduit(s). 3. The sterile individual set ( 10 ) according to claim 2 , wherein the structural association elements have a plurality of component sections arranged discontinuously along the bundle of communication conduits, such that two successive component sections are spaced apart in the longitudinal direction of the bundle of communication conduits by a maximum predetermined distance so as to substantially negate the effects of dynamic friction between the bundle of communication conduits and the peripheral wall of the flexible bag. 4. The sterile individual set according to claim 3 , wherein the structural association elements are formed by one or more flexible spiral sheath(s) having a succession of turns distributed along the bundle of communication conduits. 5. The sterile individual set according to claim 4 , wherein the structural association elements are formed by a single flexible spiral sheath arranged continuously along the bundle of communication conduits. 6. The sterile individual set according to claim 4 , wherein the structural association elements are formed by a plurality of flexible spiral sheaths arranged discontinuously along the bundle of communication conduits, such that two successive flexible spiral sheaths are spaced apart in the longitudinal direction by a predetermined maximum distance so as to substantially negate the effects of dynamic friction between the bundle of communication conduits and the peripheral wall of the flexible bag. 7. The sterile individual set according to claim 6 , wherein the maximum distance separating two successive flexible spiral sheaths is about 20 centimeters. 8. The sterile individual set according to claim 6 , wherein each of the flexible spiral sheaths has, when in place around the bundle of communication conduits, a minimum length of about 10 centimeters in the longitudinal direction. 9. The sterile individual set according to claim 6 , wherein the flexible spiral sheaths have identical structural characteristics. 10. The sterile individual set according to claim 4 , wherein two successive turns of the flexible spiral sheath(s) are spaced apart in the longitudinal direction by a maximum distance of about 4 centimeters. 11. The sterile individual set according to claim 4 , wherein the or the at least one flexible spiral sheath(s) has (have) i) a middle portion wound around the set of portions to be bundled of the bundle of communication conduits, and ii) at least one end portion wound around only a portion to be bundled of one of the communication conduits forming the bundle of communication conduits. 12. The sterile individual set according to claim 1 , comprising a plurality of separate and independent structural association elements, some being adapted to retain a plurality of portions to be bundled of the communication conduit(s) so as to form a first bundle of communication conduits that can be manipulated as such, the others being adapted to retain a plurality of other portions to be bundled of the communication conduit(s) so as to form a second bundle of communication conduits which can be manipulated as such and independently of the first bundle of communication conduits. 13. A method for packaging or unpackaging a sterile individual set according to claim 1 , consisting of using structural association elements having an external surface with lower static and dynamic friction coefficients to form the bundle of communication conduits so as to facilitate the insertion or removal of the functional member into or from the flexible bag by sliding said bundle of communication conduits relative to the peripheral wall of the flexible bag. 14. A method for packaging a sterile individual set intended for use in the process of manufacturing a biopharmaceutical product, comprising: providing a flexible bag suitable for being sterilized and equipped with a peripheral wall defining an internal space; providing a fluidic-type functional member comprising one or more communication conduit(s) which i) are suitable for the sterile fluid transfer of fluid components and ii) have an external surface; arranging around and distributing, along one or more portion(s) to be bundled of the communication conduit(s), structural association elements having an external surface with static and dynamic friction coefficients that are lower than those of the external surface of the one or more communication conduit(s) of the functional member, so as to form a bundle of communication conduits; and introducing the functional member into the flexible bag by sliding the bundle of communication conduits relative to the peripheral wall of the flexible bag. 15. The method for packaging according to claim 14 , wherein the structural association elements are formed by one or more flexible spiral sheath(s) having a succession of turns distributed along the bundle of communication conduits such that two successive turns are spaced apart in the longitudinal direction by a predetermined maximum distance so as to substantially negate the effects of dynamic friction between the bundle of communication conduits and the peripheral wall of the flexible bag. 16. The method for packaging according to claim 15 , wherein the formation of the bundle of communication conduits comprises sub-steps of: first winding one of the end portions of the or of the at least one flexible spiral sheath(s) around only one of the portions to be bundled of one of the communication conduits, then winding a middle portion of the or of the at least one flexible spiral sheath(s) around the entire set of communication conduits so as to form the bundle of communication conduits, and lastly, winding the other end portion of the one or of the at least one flexible spiral sheath(s) around only one of the portions to be bundled of one of the communication conduits forming the bundle of communication conduits. 17. A method for unpackaging a sterile individual set intended for use in the process of manufacturing a biopharmaceutical product, comprising: provid

Assignees

Inventors

Classifications

  • Enclosing successive articles, or quantities of material, e.g. liquids or semiliquids, in flat, folded, or tubular webs of flexible sheet material; Subdividing filled flexible tubes to form packages · CPC title

  • B65B5/067Primary

    in bags (B65B5/061 - B65B5/065 take precedence) · CPC title

  • Applying and securing binding material around articles or groups of articles, e.g. using strings, wires, strips, bands or tapes · CPC title

  • Applying preformed bands of continuous-ring form, e.g. elastic · CPC title

  • the container being a bag · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9963255B2 cover?
A sterile individual set for use in a process of manufacturing a biopharmaceutical product. To make it quicker and easier to grasp and use fluidic type functional members, the sterile individual set includes a sterile flexible bag having a peripheral wall defining a sterile internal space and a fluidic type functional member arranged at least partially inside the sterile internal space. The fun…
Who is the assignee on this patent?
Sartorius Stedim Biotech Sa, Sartorius Stedim Fmt Sas
What technology area does this patent fall under?
Primary CPC classification B65B5/067. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).